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Comparison of CRISPR/Cas9 and TALENs 
on editing an integrated EGFP gene in the 
genome of HEK293FT cells
Zuyong He1,2*, Chris Proudfoot2, C. Bruce A. Whitelaw2 and Simon G. Lillico2*
Abstract 
Background: Genome editors such as CRISPR/Cas9 and TALENs are at the forefront of research into methodolo-
gies for targeted modification of the mammalian genome. To date few comparative studies have been carried out to 
investigate the difference of genome editing characteristics between CRISPR/Cas9 and TALENs. While the CRISPR/Cas9 
system has overtaken TALENs as the tool of choice for most research groups working in this field, we hypothesized 
that there could be certain applications whereby the application of TALENs would have specific benefits. Here we 
compare CRISPR/Cas9 and TALEN as tools for introducing site-specific editing events at an integrated EGFP gene in 
the genome of HEK293FT cells.
Results: Guide RNAs and TALEN pairs were designed to target two loci within the EGFP gene. We found that paired 
Cas9 nucleases induced targeted genomic deletion more efficiently and precisely than two TALEN pairs. However, 
when concurrently supplied with a plasmid template spanning the two DNA double-strand breaks (DSBs) within 
EGFP, TALENs stimulated homology directed repair (HDR) more efficiently than CRISPR/Cas9 and caused fewer tar-
geted genomic deletions.
Conclusions: Our data suggest that the choice of genome editing tool should be determined by the desired 
genome editing outcome. Such a rational approach is likely to benefit research outputs for groups working in fields as 
diverse as modification of cell lines, to animal models for disease studies, or gene therapy strategies.
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Background
Until recently the precise modification of endogenous 
mammalian DNA sequences was not a practical goal for 
most research labs. The advent of genome editing tools 
has dramatically changed this landscape, with diverse 
groups around the world having embraced these new 
technologies. The CRISPR/Cas9 system in particular is 
being developed into a robust and multiplexable genome 
editing tool, enabling researchers to precisely manipu-
late specific genomic elements (Wiles et  al. 2015). This 
system relies on the bacterial endonuclease Cas9, which 
can be guided by means of simple base-pair complemen-
tarity between the first 20 nucleotides of an engineered 
guide RNA (gRNA) and a target genomic DNA sequence 
of interest that lies next to a protospacer adjacent motif 
(PAM). The recruitment of Cas9 nuclease to the target 
site results in the generation of a DNA double-strand 
break (DSB). Subsequent error prone cellular DNA repair 
processes lead to the formation of insertions, deletions or 
substitutions at the target site (Jinek et al. 2012). CRISPR/
Cas9 has been used to modify the genomes of human and 
murine cell lines with efficiencies comparable to those 
of established nucleases used for targeted genome engi-
neering (Wiles et  al. 2015) and now this approach has 
been extended to edit the genomes of model organisms, 
including zebrafish, mouse, rat, and pig (Ledford 2015).
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Before the emergence of CRSISPR/Cas9, two pro-
tein-guided genome engineering systems, zinc-finger 
nucleases (ZFNs) and transcription activator like effec-
tor nucleases (TALENs), were widely used to modify 
endogenous genes in a wide range of cell lines and living 
organisms (Joung and Sander 2013). Using these technol-
ogies numerous genomic alterations have been reported, 
including insertions, deletions, point mutations, inver-
sions, duplications and translocations, thus providing 
researchers with unprecedented tools to perform genetic 
manipulations. Compared with ZFNs, TALENs can be 
very easily and rapidly constructed using a simple “one-
to-one” correspondence between single DNA base pairs 
in a target site and two-amino-acid sequences in one TAL 
effector repeat (Boch and Bonas 2010). A large-scale test 
demonstrated that TALENs have a very high success rate 
and can be used to target almost any DNA sequence of 
interest in human cells, enabling application as a broadly 
applicable genome editing tool (Reyon et al. 2012).
Both CRISPR/Cas9 and TALENs enable genomic engi-
neering. TALENs use the FokI nuclease domain to induce 
site-specific DNA cleavage, and generate overhangs (Kim 
et al. 2013b). In contrast, in the CRISPR/Cas9 system, the 
Cas9 nuclease has been shown to cleave at a site three or 
four base pairs upstream of the PAM, and generate blunt 
ends (Jinek et  al. 2012). Due to their different cleavage 
characters, we propose that these editors may be associ-
ated with different mutation patterns. HEK293 cell lines 
have been extensively used for testing for genome edit-
ing signatures of both TALENs and CRISPR/Cas9 (Kim 
et  al. 2013a; Ren et  al. 2015), therefore in this study we 
generated a HEK293FT cell line with a single copy inser-
tion of enhanced green fluorescent protein (EGFP). EGFP 
can be converted to the closely related enhanced blue 
fluorescent protein(EBFP) through two substitutions, 
Y66H (199T > C) and Y145F (437A > T), where the Y66H 
substitution alters the chromophore π-electron structure 
within the EGFP which is critical for the blue-shifting, 
while the Y145F substitution improves the brightness 
and photostability of the EBFP (Pakhomov and Martynov 
2008). TALENs and CRISPR/Cas9 were designed to tar-
get the two substitution sites within EGFP and a com-
parison of these editors was conducted to assess their 
efficiency as mediators of disruption or deletion within 
EGFP, or conversion to EBFP when utilized in conjunc-
tion with a template for HDR.
Methods
Editor design and construction
TALENs and gRNAs were designed to target the two sub-
stitution sites required to convert EGFP to EBFP. For each 
substitution site, two TALEN pairs and two gRNAs were 
designed using the ZiFiT Targeter software (Sander et al. 
2010). TALENs were assembled using methods described 
previously (Carlson et al. 2012; Lillico et al. 2013). Briefly, 
intermediary arrays were produced for Golden Gate 
cloning as follows; 150 ng each pFUS_A, pFUS_B, pLR-X 
and pC- + 63-TAL modified vector were incubated for 10 
cycles of 5 min at 37 °C and 10 min at 16 °C, then heated 
to 50 °C for 5 min and then 80 °C for 5 min in the pres-
ence of 50 units T4 DNA ligase (New England Biolabs), 
10 units Esp3I (Fermentas), 1  ×  T4 ligase buffer (New 
England Biolabs) (TALEN RVD sequences in Additional 
file  6: Table  1). The plasmid encoding human codon 
optimized Cas9 gene (hCas9, plasmid number 41815, 
Addgene) was generated as described previously (Mali 
et al. 2013). Similar to our previous study (He et al. 2015), 
the target gRNA expression constructs were ordered as 
individual 455 bp gBlocks (IDT) (Sequence in Additional 
file 1: Figure   1A). Each gBlock was cloned into pUC19. 
The four gRNAs used in this study are listed in Addi-
tional file 1: Figure   1B. EBFP donor template and EBFP 
blocking mutation donor template were synthesized as 
gBlocks (IDT) (Additional file: 1 Figure  1C), and cloned 
into pUC19 using appropriate restriction enzymes. All 
oligonucleotide templates (Additional file 1: Figure   1D) 
were synthesized by IDT, 100 nmole synthesis purified by 
standard desalting, and resuspended to 400 μM in TE.
Generation of HEK293FTEGFP cell line using lentivirus
Human embryonic kidney 293FT cells were maintained 
in Dulbecco’s modified Eagle medium (Sigma) supple-
mented with 10 % fetal bovine serum. Cells were seeded 
at 3 × 105 cells/well in a 12-well plate, cultured for 24 h, 
then transduced with a lentiviral vector containing CMV-
EGFP at an MOI of 0.001. Following culture for a further 
48 h, FACS was used to individually seed EGFP positive 
cells into wells of a 96-well plate. Clonal populations were 
expanded and all subsequent analysis was with a sin-
gle clonal population of HEK293FTEGFP cells shown by 
Southern blot to possess a single lentiviral insertion of 
the EGFP transgene (Additional file 2: Figure  2).
Cell culture and transfection
HEK293FTEGFP cells were seeded at 1.5 × 105 cells/well 
in a 24-well plate, incubated for 24  h, and then trans-
fected with 0.3 μg Cas9 plasmid and 0.1 μg of individual 
gRNA plasmid of a pair, using X-tremeGENE HP DNA 
transfection reagent (Roche). For TALENs, 0.1 μg of each 
plasmid of the TALEN pair were co-transfected using 
the same regime as above. At day 3 post-transfection, 
genomic DNA was isolated from cells using the DNeasy 
Blood & Tissue Kit (Qiagen), following the manufac-
turer’s protocol, and used for PCR analysis and Sur-
veyor nuclease assay. For homologous recombination 
using plasmid templates, 0.2 μg Cas9 plasmid, 0.1 μg of 
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individual gRNA plasmid of a pair and 0.1 μg donor plas-
mid were transfected into HEK293FTEGFP cells; 0.1  μg 
of each plasmid of the TALEN pair and 0.1  μg donor 
plasmid were transfected into HEK293FTEGFP cells. For 
homologous recombination using oligonucleotide tem-
plates, 0.2  μg Cas9 plasmid, 0.1  μg of individual gRNA 
plasmids and 0.05 μg single-stranded donor oligonucleo-
tides (ssODN) were transfected; 0.1  μg of each plasmid 
of the TALEN pair and 0.05 μg ssODN were transfected 
into HEK293FTEGFP cells.
Flow cytometry
The fluorescence of EGFP and EBFP were detected by a 
FACSAria™ cytometer (BD Biosciences) equipped with 
a 488  nm argon laser and a 380-nm UV laser. Briefly, 
5 × 105 cells were harvested 7 days after transfection and 
resuspended in 1 ml DMEM medium supplemented with 
5  % FBS. Cell debris was excluded from analysis using 
bivariate, forward/side scatter (FSC/SSC) parameters 
and dead cells were gated from analysis using propidium 
iodide (PI). 1 × 104 gated events were acquired per sam-
ple and the values were calculated as a percentage of the 
cell population using FlowJo software (TreeStar, USA).
SURVEYOR nuclease assay and PCR analysis of genome 
modification
HEK293FTEGFP cells were transfected with DNA as 
described above. Cells were cultured for 3  days post 
transfection prior to genomic DNA extraction. Genomic 
DNA was purified using the DNeasy Blood & Tissue Kit 
(QIAGEN) following the manufacturer’s protocol. The 
genomic region flanking TALEN or gRNA target sites 
was PCR amplified using DreamTaq DNA polymerase 
(Thermo Scientific) and appropriate primers (Additional 
file  7: Table  2). SURVEYOR nuclease assay was carried 
out using methods described previously (Hsu et al. 2013). 
Briefly, 400 ng total of the PCR products were subjected 
to a denature/anneal process to enable heteroduplex for-
mation: 95 °C for 10 min; 95–85 °C ramping at −2 °C/s; 
85–25 °C at −0.25 °C/s; and 25 °C hold for 1 min. After 
reannealing, products were treated with SURVEYOR 
nuclease and SURVEYOR enhancer S (Transgenom-
ics) following the manufacturer’s recommended proto-
col, and analyzed on 2 % agarose gels. Gels were imaged 
with a Gel Doc gel imaging system (Bio-Rad). Quantifi-
cation was based on relative band intensities (Ran et al. 
2013). Similar to our previous study (He et al. 2015), to 
detect genomic deletions and homologous recombina-
tion, genomic DNA was subjected to PCR analysis using 
DreamTaq DNA polymerase (Thermo Scientific) and 
appropriate primers (Additional file  7: Table  2). PCR 
products were analyzed by agarose gel electrophoresis. 
For sequencing analysis, PCR products corresponding to 
genomic deletions or homologous recombination were 
purified using a QIAquick Gel Extraction Kit (QIAGEN) 
and cloned into pGEM-T Easy vector (Promega). Cloned 
plasmids were sequenced using M13 primers.
Statistical analysis
The counting of EGFP negative cells using FACS was 
performed in duplicate in three independent experi-
ments, with the experimental data analyzed by one-way 
ANOVA using SPSS15.0 software (SPSS Inc., USA). The 
data are shown as the mean ± SE for three independent 
experiments.
Results
EGFP disruption with CRISPR/Cas9 or TALEN
To compare the gene editing ability of CRISPR/Cas9 
and TALEN, we designed gRNAs and TALENs that tar-
geted the two reported substitution sites on EGFP, Y66H 
(199T > C) and Y145F (437A > T), predicted to convert 
EGFP into EBFP (Pakhomov and Martynov 2008). First, 
gRNA 1-1, gRNA 1-2, TALEN pair A and TALEN pair 
C were designed to cleave DNA proximal to 199T. Simi-
larly, gRNAs 2-1 and 2-2, and TALEN pairs D and F were 
designed to cleave DNA proximal to 437A (Fig. 1a). Note 
that gRNA 1-1 and gRNA 1-2 have a 14 nt overlap and 
that they target the opposite strand to gRNA 2-1 and 
gRNA 2-2. The binding sites of TALEN pairs A and C 
both target the same overlapping region, with TALEN 
pair C having a longer spacer than pair A. This also 
applies to TALEN pairs D and F.
Each CRISPR/Cas9 or TALEN pair was transfected 
into HEK293FTEGFP cells, and the efficiency of genome 
modification at day 3 was measured by Surveyor assay. 
Each of the four gRNAs induced NHEJ at their respective 
target sites, with activity ranging from 5 to 10 % (Fig. 1b). 
TALEN pair A displayed a cleavage activity comparable 
to gRNA 2-2 while TALEN pair C had a cleavage activity 
below the detection limit of the Surveyor assay. TALEN 
pair D and F displayed the most active cleavage activity of 
17 %. Seven days post-transfection, fluorescence micros-
copy showed more EGFP negative cells following treat-
ment with CRISPR/Cas9 or TALEN than in the control 
population (we observed a consistent low background 
of EGFP negative cells in our HEK293FTEGFP population 
despite re-isolation by FACS), confirmed by FACS analy-
sis (Fig. 1d).
Paired CRISPR/Cas9 is both more efficient and precise 
at generating deletions than paired TALEN pairs
To compare the ability to delete genomic regions, 
HEK293FTEGFP cells were cotransfected with plasmids 
encoding Cas9 and a pair of gRNAs, two pairs of TAL-
ENs or a pair of TALENs combined with one CRISPR/
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Fig. 1 TALEN and gRNA design, and comparison of these gene editors on EGFP gene disruption. a Schematic diagram of target sites for TALENs and 
gRNAs proximal to the two substitution sites (199T > C) and (437A > T) for conversion of EGFP to EBFP. Coloured arrow lines indicate the sequence 
used for the guide segment of gRNAs. The NGG nucleotide protospacer adjacent motif (PAM) sequences in red. Colour boxed sequences denote the 
DNA binding regions of the TALEN proteins. b Surveyor nuclease assay of genomic DNA isolated from HEK293FTEGFP cells with one copy of inte-
grated EGFP gene expressing Cas9 and gRNAs, or TALENs. NC: genomic DNA from untransfected HEK293FTEGFP cells was used a negative control. c 
The representatives of examination of EGFP negative cells in HEK293FTEGFP cells transfected with Cas9 and gRNAs, or TALENs under a phase-contrast 
and fluorescence microscope, and quantification of EGFP negative cells using by fluorescence-activated cell sorter (FACS). Arrow heads indicate 
EGFP negative cells. Scale bar of 50 μm. For FACS analysis, in each case, a total of 10,000 events were counted
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Cas9. Three days post transfection, genomic DNA was 
prepared from cell pools and analysed by PCR. PCR 
across the target region using primers site1 F and site2 
R (Additional file  7: Table  2) produced a full length 
product of 509 bp, or in the event of a genomic deletion 
between target sites a product approximating 250  bp. 
The truncated PCR product was most apparent in cells 
transfected with paired CRISPR/Cas9 nuclease reagents, 
less apparent when gRNA 1-1 was paired with TALEN 
pair D or F, and barely observed when TALEN pair A 
was combined with pair D (Fig. 2a). Following extended 
culture the deletion frequency declined by day 10 and 
thereafter remained stable until day 20 (Fig.  2b), con-
sistent with data previously reported for NHEJ-induced 
indels (Carlson et al. 2012).
Deletion-specific PCR products (yellow arrow heads 
Fig.  2a) were cloned and sequenced, confirming that 
in each case the intervening DNA segment had been 
deleted (Fig.  2c–f). Truncated DNA generated through 
the pairing of gRNA 1-1 and gRNA 2-2 revealed that the 
majority of events (16/17) represented a precise ligation 
ofthe breakpoint junctions generated by Cas9 (Fig. 2c).
ZFNs and TALENs both use a fused FokI nuclease to 
cleave their double-stranded DNA target sites, generat-
ing heterogeneous ends which are then rejoined through 
NHEJ. The resultant breakpoint junction sequences often 
show small indels associated with micro-homologies of 
1–5 bases (Lee et  al. 2010; Xiao et  al. 2013). From five 
sequenced clones derived from TALEN pair A and D, 
we observed deletion and micro-homology repair at the 
breakpoint (Fig. 2e). When genomic deletion was gener-
ated by the combination of CRISPR/Cas9 and a TALEN 
pair, additional deletions were more often observed on 
both breakpoint junctions (Fig. 2f ). It is known that the 
NHEJ ligation step can be preceded by annealing over 
micro-homology of a few base pairs, leading to poten-
tial deletion of unpaired bases (Ray and Langer 2002). 
Therefore, it is possible that the overhangs generated by 
the FokI of TALEN pair F and not the Cas9 nuclease was 
largely responsible for the observed deletions that were 
induced during the ligation process.
Two TALEN pairs mediate HDR more efficiently than paired 
gRNAs
Previous reports on TALEN or CRISPR/Cas9 medi-
ated homology-directed repair (HDR) using plasmid or 
ssODN templates have focused on conversion of a sin-
gle site. Here we compared CRISPR/Cas9 and TALEN 
for the simultaneous substitution of 2 bases within the 
EGFP gene separated by 238 bp, with the aim of convert-
ing EGFP to EBFP (Fig.  3a). Co-transfection of gRNA 
1-2, Cas9 andssODN1 resulted in approximately 0.06  % 
EBFP positive cells, with this number rising to 0.8  % 
EBFP positive cells within the EGFP negative population 
(Fig. 3b, c; Additional file 8: Table 3). Concurrent delivery 
of 2 guides (gRNA 1-2 and gRNA 2-1) and 2 templates 
(ssODN1 and ssODN2) produced a comparable pro-
portion of EGFP negative cells as compared to delivery 
of a single guide (8.21 vs 8  %), with less than 0.01  % of 
these cells being EBFP positive (Additional file  3: Fig-
ure    3A, Additional file  8: Table  3). This suggests that 
concurrent DSBs induced by the paired gRNA/Cas9 
resulted in preferential deletion of the intervening DNA 
rather than supporting HDR. This is corroborated by the 
increased frequency of the truncated PCR product in the 
FACS sorted EGFP negative cells relative to the unsorted 
population (Fig. 3d). When two TALEN pairs (A and F) 
together with the same ssODN1 and ssODN2 were intro-
duced into HEK293FTEGFP cells, FACS analysis revealed 
that 0.035 % became EBFP positive (1.92 % of the EGFP 
negative population) (Additional file  3: Figure    3A). In 
this case the generation of paired DSBs did not enhance 
the disruption of EGFP, but did enhance concurrent HDR 
at two proximal sites on the same chromosome. One pos-
sible explanation is that individual TALEN pairs gener-
ated temporally separated DSB and HDR events, thereby 
avoiding inducing genomic deletion. This hypothesis is 
supported by sequence data from the full length PCR 
products derived from EGFP negative cells, whereby all 
sequenced events from the two TALEN pairs had an indel 
corresponding to the TALEN pair A target site whilst the 
TALEN pair F target site remaining intact. In contrast, 
when paired guides were used, indels were observed at 
both target sites in most sequenced events (Additional 
file 3: Figure  3B). When supplied with a plasmid template 
spanning the two target sites, paired gRNA/Cas9 and two 
pairs of TALENs generated similar HDR results whereby 
few EBFP positive cells were detected in the EGFP posi-
tive population (Additional file 3: Figure  3A, Additional 
file 8: Table 3).
One explanation for the low conversion rate of EGFP 
to EBFP, when using gRNA/Cas9 or TALEN with either 
ssODN or plasmid as template for HDR, is that genomic 
cleavage and NHEJ at the target sites can occur sub-
sequent to any HDR event (i.e. re-cutting). In order to 
investigate this possibility we designed template mol-
ecules (ssODN and plasmid) containing silent blocking 
mutations (BM) in addition to the desired coding base 
changes, with the intention that once an HDR event had 
introduced the desired mutation into the EGFP target 
sequence, the modified site would differ sufficiently from 
the original target sequence that re-cutting would not 
occur (Fig.  4a). The introduction of blocking mutations 
on oligonucleotide templates substantially improved the 
HDR efficiency, as evidenced by 0.738  % EBFP positive 
cells (2.86 % of the EGFP negative population) detected 
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(See figure on previous page.) 
Fig. 2 A comparison of TALEN and CRIPSR/Cas9 on inducing targeted genomic deletions. a Genomic deletions detected using PCR. Arrow heads 
indicate deletion-specific PCR products cloned for sequencing. b Genomic deletions detected at day 3, day 10 and day 20 after HEK293FTEGFP cells 
transfected with paired Cas9. c DNA sequences of deletion-specific PCR products obtained using gRNA 1-1, gRNA 2-2 and Cas9. Target site PAM 
sequences in red, and gRNA-matching sequences in bold upper case letters. Predicted cleavage sites represented by green and red arrow heads. 
Inserted bases in blue. Dashes indicate deleted bases. d DNA sequences of deletion-specific PCR products obtained using gRNA 1-2, gRNA 2-1 and 
Cas9. The suspected second PAM in gRNAs is shown in blue, and predicted cleavage sites around second PAM are represented by grey arrow heads. 
e DNA sequences of deletion-specific PCR products obtained using TALEN pair A and D. The target sites of TALEN pair A in underlined boldface letters, 
and highlighted in yellow. The target sites of TALEN pair D are highlighted in green. Microhomologies underlined. f DNA sequences of deletion-
specific PCR products obtained using gRNA 1-1, Cas9 and TALEN pair F
Fig. 3 The design of single-stranded oligodeoxynucleotides (ssODNs) and plasmid donor, and the comparison of HDR efficiencies between 
TALEN and CRISPR/Cas9. a The schematic diagram shows two 90-mer ssODN and a plasmid donor DNA used to incorporate the two substitutions 
(199T > C) and (437A > T) into the EGFP locus. Predicted cleavage sites of CRISPR/Cas9 or TALEN are indicated by coloured arrow heads. b The set up 
of controls for FACS analysis. HEK293FT cell line was used as EGFP and EBFP negative control. HEK293FTEGFP cell line was used as EGFP positive and 
EBFP negative control. HEK293FT cells transiently transfected with a plasmid encoding EBFP were used as EBFP positive control. In each case, a total 
of 10,000 events were counted. c Representatives of the FACS analysis of EBFP positive cells generated via HDR by using TALEN or CRISPR/Cas9 with 
donor templates. NG: EGFP negative cells. d Detection of targeted genomic deletions in sorted EGFP negative populations using PCR. NC: genomic 
DNA from untransfected HEK293FTEGFP cells was used as negative control. US: genomic DNA from HEK293FTEGFP cells transfect paired Cas9 and 
ssODN or plasmid donor was used for PCR. S: genomic DNA from sorted EGFP negative cells from HEK293FTEGFP cells transfected with paired Cas9 
and ssODN or plasmid donor
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when ssODN1-BM was co-delivered into HEK293FTEGFP 
cells with gRNA 1-1 and Cas9 (Fig. 4b; Additional file 4: 
Figure  4A, Additional file 3: Table 3).
Steric hindrance between two adjacent Cas9-gRNA 
complexes could be a factor that negatively impacts on 
indel formation. To investigate whether this was likely 
we co-delivered two guide RNAs (gRNA 1-1 and gRNA 
1-2), displaying a 14  bp overlap, concurrently to HEK-
293FTEGFP cells with Cas9 and ssODN1-BM. Surpris-
ingly, we found that delivery of the pair of guides resulted 
in significantly more EGFP negative cells than either 
guide alone; 16.8  % for the pair versus 9.7  % for gRNA 
1-1 and 14.5  % for gRNA 1-2. Moreover, paired guides 
generated a comparable conversion rate to EBFP positive 
cells (0.66 %) when compared to gRNA 1-1 alone (0.74 %) 
(Additional file 4: Figure   4A, Additional file 3: Table 3). 
In contrast, TALEN pair A or C as a single delivery 
induced less than 0.01 % EBFP conversion with the sup-
ply of ssODN1-BM (Additional file 4: Figure   4A, Addi-
tional file 3: Table 3).
Fig. 4 The design of single-stranded oligodeoxynucleotides (ssODNs) and plasmid donor with blocking mutations, and the comparison of HDR 
efficiencies between TALEN and CRISPR/Cas9. a The schematic diagram shows two 120-mer ssODN and a plasmid donor DNA with blocking muta-
tions (BMs) used to incorporate the two substitutions (199T > C) and (437A > T) into the EGFP locus. Predicted cleavage sites of CRISPR/Cas9 or 
TALEN are indicated by coloured arrow heads. A silent G to T mutation was introduced on ssODN1-BM and EBFP-BM plasmid to create a silent HindIII 
site, and a silent G to C mutation was introduced on ssODN2-BM to create a silent XhoI site. More silent mutations were introduced on ssODN and 
plasmid template to form the blocking mutations (BMs) for each TALEN arm and gRNA. b Representatives of the FACS analysis of EBFP positive cells 
generated via HDR by using TALEN or CRISPR/Cas9 with donor templates with blocking mutations. NG: EGFP negative cells. c The quantification of 
EBFP positive cells in extended cultured EGFP negative cells sorted from HEK293FTEGFP cells transfected with TALEN or CRISPR/Cas9 conjugated with 
donor templates with blocking mutations. In each case, a total of 10,000 events were counted
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When supplied with both ssODN1-BM and ssODN2-
BM, either paired guides/Cas9 or paired TALEN pairs 
were inefficient at inducing concurrent HDR at both 
target sites as determined by FACS (Additional file  4: 
Figure   4B, Additional file 3: Table 3) or RFLP (Fig. 5a). 
As blocking mutations on the oligonucleotide templates 
should prevent re-cutting following HDR, HDR at one or 
both target sites should prevent deletion of the interven-
ing fragment through NHEJ-mediated breakpoint junc-
tion re-joining. Sequence analysis of PCR clones derived 
from sorted EBFP positive cells derived from transfec-
tion with gRNA1-1, gRNA2-1, ssODN1-BM, ssODN2-
BM, and Cas9, revealed that no concurrent HDR was 
found from 10 sequenced events (Additional file  5: 
Figure  5A).
Blocking mutations on the donor plasmid increased 
the percentage of EBFP positive cells from 0.013 to 
0.055  % when gRNA1-1 and gRNA2-1 were co-deliv-
ered, with 0.27  % EBFP cells appearing in the EGFP 
negative population (Additional file  4: Figure    4B, 
Additional file  8: Table  3). Conversion from EGFP 
to EBFP positive cells were also detected using other 
paired guide/Cas9 combinations (Additional file  8: 
Table 3). Paired delivery of TALEN pairs A and D with 
the EBFP-BM donor plasmid resulted in a conversion 
rate of 0.02 % EBFP, or 0.334 % EBFP positive cells in 
Fig. 5 Analysis of HDR mediated by TALEN or CRISPR/Cas9 using RFLP assay. a Hind II or Xho -digested, or co-digested genomic DNA isolated 
from cells derived from HEK293FTEGFP cells transfected with paired Cas9 or two TALEN pairs with ssODN1-BM and ssODN2-BM. NC: genomic DNA 
from untransfected HEK293FTEGFP cells was used as negative control. US: genomic DNA from unsorted HEK293FTEGFP cells transfect with indicated 
constructs. NG: genomic DNA from sorted EGFP negative cells. EBFP: genomic DNA from sorted EBFP positive cells from extended cultured EGFP 
negative populations. Red and green arrow head indicate the expected size of HindIII-digested and XhoI-digested product respectively. b Detection 
of targeted genomic deletions in differently sorted populations from HEK293FTEGFP cells transfected with indicated constructs. Symbols as shown in 
(a). c HindIII-digested genomic DNA isolated from cells derived from HEK293FTEGFP cells transfected with paired Cas9 or two TALEN pairs with EBFP-
BM plasmid donor. Symbols as those shown in (a)
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the EGFP negative population (Additional file  4: Fig-
ure    4B, Additional file  3: Table  3). In comparison to 
the simultaneous delivery of 2 ssODNs with blocking 
mutations, a plasmid with blocking mutations proved a 
superior donor. The proportion of EBFP positive cells 
in the EGFP negative population was approximately 
doubled when plasmid template was utilised instead 
of the 2 ssODNs (0.167 vs 0.088 %; Fig. 4c). The result 
was similar when TALEN pairs A and D were co-trans-
fected with the EBFP-BM donor plasmid (0.168 %). By 
contrast, no EBFP positive cells were detected when 
ssODN1-BM and ssODN2-BM were used in con-
junction with the paired TALENs (Fig.  4c). Sequence 
analysis of PCR products from EBFP positive cells gen-
erated from EBFP-BM mediated HDR by either paired 
gRNA/Cas9 or two TALEN pairs, showed that simul-
taneous site conversion events could be induced using 
either approach (Additional file  5: Figure    5B and C). 
When supplied with the EBFP-BM plasmid, TALEN 
pairs were less efficient at inducing genomic dele-
tions than gRNAs, as revealed by PCR (Fig.  5b) but 
were more efficient at stimulating concurrent HDR as 
determined by RFLP (Fig. 5c). As Cas9 co-transfected 
with a ssODN template was more efficient at stimulat-
ing HDR at a single target site than simultaneously at 
adjacent sites (Fig.  4c), we investigated the possibility 
of carrying out the EGFB to EBFP conversion in a step-
wise manner. First we mutated Y145F (437A > T) using 
the ssODN2-BM in conjunction with either gRNA2-
1, gRNA2-2, or both, and subsequently used the same 
cells to mutate the Y66H (199T  >  C) using ssODN1-
BM and gRNA1-1. Using this approach we generated 
up to 1.15 % EBFP positive cells as a proportion of the 
whole population, translating as 4.05 % EBFP positive 
cells as a proportion of the EGFP negative population 
(Additional file 4: Figure  4C).
Discussion
We have carried out a systematic comparison of CRISPR/
Cas9 and TALEN editing of an EGFP gene integrated in 
the genome of HEK293FT cells. Paired gRNAs induced 
targeted genomic deletion more efficiently than two 
TALEN pairs, and generated more precisely rejoined 
breakpoint junctions. When supplied with a plasmid 
template spanning the paired DSBs, TALENs stimu-
lated homology directed repair (HDR) more efficiently 
than CRISPR/Cas9, and induced fewer targeted genomic 
deletions.
Both point mutations and chromosomal deletions 
can be associated with genetic diseases (Stankiewicz 
and Lupski 2010). To better understand the roles 
these genomic modifications play in complex dis-
eases, it would be advantageous to precisely replicate 
them by targeted modification of higher eukaryotic 
cells and organisms. Using two DNA editor pairs that 
are targeted to the same chromosome it is possible 
to generate deletions of chromosomal segments in 
cell lines or live organisms (He et  al. 2015; Lee et  al. 
2010; Xiao et  al. 2013). It has been well understood 
that the FokI nuclease of ZFNs and TALENs cleaves 
DNA within the spacer between the paired binding 
sites and generates overhangs, which can then be re-
joined through NHEJ (Kim et  al. 2013b). The NHEJ 
pathway is extremely flexible and can proceed through 
many rounds of enzymatic activity involving resec-
tion of overhangs by nucleases, gap fill-in by polymer-
ase and DNA ligation. Moreover, when the classical 
NHEJ pathway is impeded, other cellular repair fac-
tors can substitute for it. This substitution, which is 
called alternative end joining (alt-EJ), backup NHEJ, 
or microhomology-mediated end joining (MMEJ), var-
ies considerably in efficiency among species and cell 
types (Lieber and Wilson 2010). Therefore, chromo-
somal repair by NHEJ can potentially result in diverse 
products depending on the repair mechanisms that 
are induced. Heterogeneity associated withmicro-
homologies were often observed at the junction of 
paired ZFN-directed deletion events (Lee et  al. 2010) 
and were also observed at the junction of TALEN-
mediated deletion events in this study. In contrast the 
junctions of paired Cas9 nuclease-directed deletions 
observed in this study were surprisingly homogene-
ous, with the breakpoint junctions three or four base 
pairs upstream of the PAM (Jinek et  al. 2012). NHEJ 
ligation requires the association of two double-strand 
ends. In one model, the Ku:DNA-PKcs complex forms 
a tight dimer across the break, such that DNA-PKcs 
autophosphorylation occurs, at which point protection 
of the DNA ends is released to allow enzymatic action. 
In a second model, less rigid associations are achieved 
by tethering two ends close to each other but leaving 
the termini free. In this model, with insufficient base 
pairing of overhangs to hold a double-strand break 
together, structural components facilitate the equilib-
ria of many potential alignments of the ends with final 
synapsis (i.e. the holding together of the two DNA 
ends) achieved only transiently within the active sites 
of the catalytic enzymes. In addition, micro-homol-
ogy could be generated de novo even when two blunt 
ends are joined, which may occur by the compensatory 
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addition or deletion of nucleotides at opposing ends of 
the double-strand break (Lieber and Wilson 2010). It is 
noteworthy that this was not observed in the current 
study. Therefore, the repairing of the blunt ends gen-
erated by paired guides/Cas9 by the MMEJ pathway 
seems an unfavoured outcome. Deletions generated by 
paired guides/Cas9 could provide an interesting field 
for further investigation into alternative pathways of 
NHEJ.
Our comparison of TALENs with CRISPR/Cas9 has 
shown that the latter is more efficient at generating frag-
ment deletion, and HDR at a single site, but that TALENs 
plus a plasmid template were more efficient at mediating 
concurrent HDR at two proximal DSBs with reduced risk 
of deletion of the intervening chromosomal sequence. 
If the first step of HDR is limiting, TALENs would be 
more efficient than CRISPR/Cas9 at initiating the pro-
cess as they generate overhangs which could be readily 
used for strand invasion when a dsDNA template span-
ning the two target sites is present. More efficient initia-
tion of HDR would have the knock-on consequence of 
reduced end-break rejoining by NHEJ. It is worth not-
ing that ssODNs were less efficient than dsDNA tem-
plates at stimulating HDR at concurrent DSBs generated 
by paired gRNA/Cas9 or paired TALEN pairs (Fig.  5c; 
Additional file 4: Figure  4B). It is possible that the HDR 
mediated by ssODNs is through a pathway similar to 
synthesis-dependent strand annealing (Sung and Klein 
2006); instead of invading the homologous dsDNA, the 
ssODN may anneal directly with the single stand over-
hang on one side of the DSB and subsequently anneal 
with the overhang on the other side of the DSB, followed 
by gap-filling and ligation. When concurrent DSBs occur, 
the displaced extended single-stranded tail may not find 
the single-stranded overhang on the other DSB end. 
Resolution of the exchanged DNA strands can result in 
crossover, whereby segments of the interacting dsDNA 
are exchanged. Therefore, TALENs present advantages 
when stimulating simultaneous gene conversion at two 
sites within one chromosome when supplied with a 
dsDNA template spanning the two target sites.
Conclusions
Through comparison of CRISPR/Cas9 and TALENs on 
editing an integrated EGFP gene we found that CRISPR/
Cas9 was superior for targeted genomic deletion, while 
TALENs outperformed CRISPR/Cas9 for stimulation of 
concurrent HDR at proximal sites within a single gene. 
These two genome editing tools are therefore comple-
mentary to each other.
Additional files
Additional file 1: Figure 1. gRNA expression vectors and donor tem-
plates used in this study. (A) U6 promoter based expression scheme for 
the gRNAs. The use of U6 promoter constrains the first position in the RNA 
transcript to be a “G”. (B) The target sequences of four gRNAs used in this 
study are listed. The PAM sequence in red. (C) The sequence of EBFP and 
EBFP-BM donor templates which were synthesized as gBlocks (IDT). (D) 
Sequences of oligonucleotide templates used in this study.
Additional file 2: Figure 2. Southern blot analysis of the copy number 
of the integrated EGFP gene. (A) Schematic diagram of the lenti-virus 
construct used for generating HEK293FTEGFP cell line. (B) The genomic 
DNA was digested with NcoI or XhoI, a probe derived from the fragment 
between EcoRI andNcoI was used for blotting. As EGFP was integrated 
into genome via the long terminal repeat (LTR)-directed integration, if 
multiple integration happened, different sized of blotted genomic frag-
ments can be detected.
Additional file 3: Figure 3. A comparison of TALEN and CRIPSR/Cas9 
on stimulating HDR with ssODNs or plasmid donor. (A) FACS analysis of 
EBFP positive cells generated via HDR by using TALEN or CRISPR/Cas9 
with indicated donor templates. HEK293FT cell line was used as EGFP and 
EBFP negative control. HEK293FTEGFP cell line was used as EGFP positive 
and EBFP negative control. HEK293FT cells transiently transfected with a 
plasmid encoding EBFP were used as EBFP positive control.NG represents 
EGFP negative cells. In each case, a total of 10,000 events were counted. 
(B) Sequence analysis of the editing results on target sites in EGFP nega-
tive cells produced by TALEN or CRISPR/Cas9 with ssODN or plasmid tem-
plates. Target site PAM sequences in red, and gRNA-matching sequences 
in bold upper case letters. Target sites of TALEN pair A underlined 
boldface letters, and highlighted in yellow, and target sites of TALEN pair 
F highlighted in green. Intended substitution sites were underlined, and 
highlighted in yellow. Inserted bases are shown in blue. Dashes indicate 
deleted bases.
Additional file 4: Figure 4. A comparison of TALEN and CRIPSR/Cas9 on 
stimulating HDR with ssODNs or plasmid donor with blocking mutations. 
(A) FACS analysis of EBFP positive cells generated via HDR on 199T > C 
substitution site on EGFP by using TALEN or CRISPR/Cas9 with indicated 
donor templates. HEK293FT cell line was used as EGFP and EBFP negative 
control. HEK293FTEGFP cell line was used as EGFP positive and EBFP nega-
tive control. HEK293FT cells transiently transfected with a plasmid encod-
ing EBFP were used as EBFP positive control.NG represents EGFP negative 
cells. In each case, a total of 10,000 events were counted. (B) FACS analysis 
of EBFP positive cells produced from simultaneous HDR on 199T > C 
and 437A > T target sites by using two TALEN pairs and paired Cas9 with 
ssODN-BMs or EBFP-BM templates. (C) FACS analysis of EBFP positive cells 
produced by sequential HDR on 437A > T and 199T > C target sites by 
using two paired Cas9 with ssODN-BMs.
Additional file 5: Figure 5. Sequence analysis of cloned PCR products 
from EBFP positive cells derived from HEK293FTEGFP cells transfected with 
gRNA1-1, gRNA2-1, Cas9 and ssODN-BMs (A) or EBFP-BM template (B), or 
TALEN pair A and D with EBFP-BM template (C). Target site PAM sequences 
in red, and gRNA-matching sequences in bold upper case letters. The 
target sites of TALEN pair A underlined boldface letters, and highlighted in 
yellow. The target sites of TALEN pair D highlighted in green. The intended 
substitution site underlined, and highlighted in yellow. Blocking muta-
tions in red, the silent restriction sites in green and highlighted in yellow, 
and inserted bases in blue. Dashes indicate deleted bases.
Additional file 6: Table 1. TALEN sequences.
Additional file 7: Table 2. Primer sequences.
Additional file 8: Table 3. Comparison of HDR frequencies between 
CRIPSR/Cas9 and TALEN using oligonucleotide or plasmid templates.
Page 12 of 12He et al. SpringerPlus  (2016) 5:814 
Authors’ contributions
SL, ZH, BW conceived the study and wrote the manuscript. ZH carried out the 
experiments.SL, ZH, BW, CP analysed the data. All authors read and approved 
the final manuscript.
Author details
1 State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen Uni-
versity, Guangzhou 510006, People’s Republic of China. 2 The Roslin Institute 
and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter 
Bush Campus, Edinburgh EH25 9RG, UK. 
Acknowledgements
We are grateful to Claire Neil and Rachael Huddart for their input and to 
George Church (Harvard Medical School) for providing us the plasmid encod-
ing Cas9. This work was supported by the joint funds of NSFC-Guangdong 
(U1201213); National Transgenic Breeding Program (2014ZX08006005-005) 
and Chinese Scholarship Scheme [ZH: Grant Number 201208440261]; Biotech-
nology and Biological Sciences Research Council [Grant Number BBL007371/1, 
BB/J004316/1]; research funds from Genus plc [CP and CBAW] and the Euro-
pean Cooperation in Science and Technology Action [Grant Number BM1308].
Competing interests
The authors declare that they have no competing interests.
Received: 30 March 2016   Accepted: 7 June 2016
References
Boch J, Bonas U (2010) Xanthomonas AvrBs3 family-type III effectors: discovery 
and function. Annu Rev Phytopathol 48:419–436
Carlson DF, Tan W, Lillico SG, Stverakova D, Proudfoot C, Christian M, Voytas DF, 
Long CR, Whitelaw CB, Fahrenkrug SC (2012) Efficient TALEN-mediated 
gene knockout in livestock. Proc Natl Acad Sci U S A 109:17382–17387
He Z, Proudfoot C, Mileham AJ, McLaren DG, Whitelaw CB, Lillico SG (2015) 
Highly efficient targeted chromosome deletions using CRISPR/Cas9. 
Biotechnol Bioeng 112:1060–1064
Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine 
EJ, Wu X, Shalem O, Cradick TJ, Marraffini LA, Bao G, Zhang F (2013) DNA 
targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 
31:827–832
Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A 
programmable dual-RNA-guided DNA endonuclease in adaptive bacte-
rial immunity. Science 337:816–821
Joung JK, Sander JD (2013) TALENs: a widely applicable technology for tar-
geted genome editing. Nat Rev Mol Cell Biol 14:49–55
Kim Y, Kweon J, Kim A, Chon JK, Yoo JY, Kim HJ, Kim S, Lee C, Jeong E, Chung 
E, Kim D, Lee MS, Go EM, Song HJ, Kim H, Cho N, Bang D, Kim JS (2013a) 
A library of TAL effector nucleases spanning the human genome. Nat 
Biotechnol 31:251–258
Kim Y, Kweon J, Kim JS (2013b) TALENs and ZFNs are associated with different 
mutation signatures. Nat Methods 10:185
Ledford H (2015) CRISPR, the disruptor. Nature 522:20–24
Lee HJ, Kim E, Kim JS (2010) Targeted chromosomal deletions in human cells 
using zinc finger nucleases. Genome Res 20:81–89
Lieber MR, Wilson TE (2010) SnapShot: nonhomologous DNA end joining 
(NHEJ). Cell 142(496–496):e491
Lillico SG, Proudfoot C, Carlson DF, Stverakova D, Neil C, Blain C, King TJ, Ritchie 
WA, Tan W, Mileham AJ, McLaren DG, Fahrenkrug SC, Whitelaw CB (2013) 
Live pigs produced from genome edited zygotes. Sci Rep 3:2847
Mali P, Yang LH, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church 
GM (2013) RNA-guided human genome engineering via Cas9. Science 
339:823–826
Pakhomov AA, Martynov VI (2008) GFP family: structural insights into spectral 
tuning. Chem Biol 15:755–764
Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, Scott 
DA, Inoue A, Matoba S, Zhang Y, Zhang F (2013) Double nicking by 
RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 
154:1380–1389
Ray A, Langer M (2002) Homologous recombination: ends as the means. 
Trends Plant Sci 7:435–440
Ren C, Xu K, Liu Z, Shen J, Han F, Chen Z, Zhang Z (2015) Dual-reporter sur-
rogate systems for efficient enrichment of genetically modified cells. Cell 
Mol Life Sci 72:2763–2772
Reyon D, Tsai SQ, Khayter C, Foden JA, Sander JD, Joung JK (2012) FLASH 
assembly of TALENs for high-throughput genome editing. Nat Biotechnol 
30:460–465
Sander JD, Maeder ML, Reyon D, Voytas DF, Joung JK, Dobbs D (2010) ZiFiT 
(Zinc Finger Targeter): an updated zinc finger engineering tool. Nucleic 
Acids Res 38:W462–W468
Stankiewicz P, Lupski JR (2010) Structural variation in the human genome and 
its role in disease. Annu Rev Med 61:437–455
Sung P, Klein H (2006) Mechanism of homologous recombination: media-
tors and helicases take on regulatory functions. Nat Rev Mol Cell Biol 
7:739–750
Wiles MV, Qin W, Cheng AW, Wang H (2015) CRISPR-Cas9-mediated genome 
editing and guide RNA design. Mamm Genome 26:501–510
Xiao A, Wang Z, Hu Y, Wu Y, Luo Z, Yang Z, Zu Y, Li W, Huang P, Tong X, Zhu Z, 
Lin S, Zhang B (2013) Chromosomal deletions and inversions mediated 
by TALENs and CRISPR/Cas in zebrafish. Nucleic Acids Res 41:e141
